A Pharmacokinetic and Pharmacodynamic Study of Two Formulations of Omega-3 One Gram Capsules After Single and Multi-Dose Administrations Under Fed Conditions

Trial Profile

A Pharmacokinetic and Pharmacodynamic Study of Two Formulations of Omega-3 One Gram Capsules After Single and Multi-Dose Administrations Under Fed Conditions

Completed
Phase of Trial: Phase I/II

Latest Information Update: 12 Sep 2017

At a glance

  • Drugs MAT 9001 (Primary) ; Antihyperlipidaemics
  • Indications Dyslipidaemias; Hypertriglyceridaemia
  • Focus First in man; Pharmacokinetics
  • Sponsors Matinas BioPharma
  • Most Recent Events

    • 12 Sep 2017 Status changed from active, no longer recruiting to completed, according to a Matinas BioPharma media release.
    • 15 Jun 2015 PK/PD trial data presented at the National Lipid Association (NLA) Scientific Sessions, as per Matinas BioPharma media release.
    • 15 Jun 2015 PK/PD results published in the Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top